HMC

Harvard Management Company Portfolio holdings

AUM $1.44B
This Quarter Return
+4.96%
1 Year Return
+33.17%
3 Year Return
+230.83%
5 Year Return
+163.57%
10 Year Return
+194.2%
AUM
$807M
AUM Growth
+$807M
Cap. Flow
+$3.01M
Cap. Flow %
0.37%
Top 10 Hldgs %
81.37%
Holding
47
New
Increased
1
Reduced
2
Closed
1

Top Buys

1
GRAB icon
Grab
GRAB
$12M

Sector Composition

1 Communication Services 43.32%
2 Consumer Discretionary 19.46%
3 Healthcare 17%
4 Technology 15.93%
5 Financials 1.24%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
VIGL
26
DELISTED
Vigil Neuroscience
VIGL
$3.62M 0.45% 289,460
NRIX icon
27
Nurix Therapeutics
NRIX
$714M
$3.46M 0.43% 314,762
KNTE
28
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$3.04M 0.38% 498,001
FULC icon
29
Fulcrum Therapeutics
FULC
$351M
$2.99M 0.37% 410,714
CFLT icon
30
Confluent
CFLT
$6.85B
$2.9M 0.36% 130,383
PCT icon
31
PureCycle Technologies
PCT
$2.57B
$2.06M 0.26% 2,498,170
GBIO icon
32
Generation Bio
GBIO
$40.4M
$2.01M 0.25% 510,354
PACB icon
33
Pacific Biosciences
PACB
$393M
$1.87M 0.23% 229,144
KITT icon
34
Nauticus Robotics
KITT
$38.2M
$1.87M 0.23% 500,000
PRAX icon
35
Praxis Precision Medicines
PRAX
$958M
$1.85M 0.23% 778,517
SANA icon
36
Sana Biotechnology
SANA
$777M
$1.85M 0.23% 468,749
AFRM icon
37
Affirm
AFRM
$28.8B
$1.68M 0.21% 173,560
TNYA icon
38
Tenaya Therapeutics
TNYA
$184M
$1.35M 0.17% 673,270
DYN icon
39
Dyne Therapeutics
DYN
$1.92B
$1.24M 0.15% 107,252
XLO icon
40
Xilio Therapeutics
XLO
$36.3M
$1.12M 0.14% 416,059
MCRB icon
41
Seres Therapeutics
MCRB
$166M
$738K 0.09% 131,847
PRDS
42
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$676K 0.08% 400,000
DBTX
43
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$674K 0.08% 328,798
IRON icon
44
Disc Medicine
IRON
$2.07B
$497K 0.06% 25,000 -225,000 -90% -$4.48M
SRZN icon
45
Surrozen
SRZN
$104M
$481K 0.06% 826,852
DNTH icon
46
Dianthus Therapeutics
DNTH
$759M
$131K 0.02% 332,610
LAUR icon
47
Laureate Education
LAUR
$4.05B
-101,804 Closed -$1.07M